Calendar Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange 18:00:00 2023-10-05 EDT 5-day change 1st Jan Change
0.175 CAD +45.83% Intraday chart for Mydecine Innovations Group Inc. +29.63% -61.11%

Chart calendar Mydecine Innovations Group Inc.

9c79f.BHOVXo85kUNB59iWVwIAgUfEpNkFtwl24mEyUWUdNjs.d0b-c-VWxg0ys6jkJ1tH5XWpkfRi-n0vhC5IECBXDkM8Gv4Htm3XdCKyjQ~6c1fcdf8f9aa435a23818b6644cdb9d4

Upcoming events on Mydecine Innovations Group Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-07-04 Annual General Meeting
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)

Past events on Mydecine Innovations Group Inc.

2023-11-15 04:49 Q3 2023 Earnings Release
2023-08-14 20:32 Q2 2023 Earnings Release
2023-07-03 Extraordinary Shareholders Meeting
2023-05-16 16:01 Q1 2023 Earnings Release
2023-05-04 Annual General Meeting
2023-03-31 20:21 Q4 2022 Earnings Release
2022-08-15 21:46 Interim 2022 Earnings Release
2022-07-20 Annual General Meeting
2022-05-16 21:28 Q1 2022 Earnings Release
2022-03-31 20:53 FY 2021 Earnings Release
2022-03-27 Maxim Growth Conference
2021-12-05 H.C. Wainwright Psychedelics Conference
2021-11-10 19:30 Horizons Veterans & Families Forum - Panel
2021-11-07 Microdose Wonderland Miami Meeting - One on One
2021-09-22 15:00 M-Vest Maxim Group Advances in Mental Health Virtual Conference - Panel
2021-09-22 10:00 Maxim Group and M-Vest Advances in Mental Health Virtual Conference - Panel
2021-09-21 Maxim Group and M-Vest Advances in Mental Health Virtual Conference
2021-09-21 13:15 Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
2021-09-20 14:00 Annual General Meeting
2021-09-13 07:00 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2020 2021
Net sales
Million CAD
Released
Forecast
Spread
0,06


0,01
0,06
-88.3%
EBITDA
Million CAD
Released
Forecast
Spread
0,00


-25,0
-23,5
-6.5%
EBIT
Million CAD
Released
Forecast
Spread
0,00


-28,7
-26,1
-9.97%
Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
0,00


-28,9
-22,7
-27.22%
Net income
Million CAD
Released
Forecast
Spread
-26,9


-28,9
-22,7
-27.22%
EPS
CAD
Released
Forecast
Spread
0,00


-6,00
-4,75
-26.32%
Announcement Date30/04/2131/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,04
-99.82%
-0,01
0,09
-115.32%
0,00
0,30
-



Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



Net income
Million CAD
Released
Forecast
Spread
-4,54
-5,03
9.77%
-10,9
-5,02
-116.76%
-5,64
-5,94
5.01%



EPS
CAD
Released
Forecast
Spread
-1,00
-0,50
-100%
-2,00
-1,00
-100%
-1,20
-1,00
-20%
-0,35


Announcement Date15/11/2131/03/2216/05/2215/08/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MYCO.F Stock
  4. MYCO Stock
  5. Calendar Mydecine Innovations Group Inc.